Lung cancer
Conditions
Interventions
Intervention group:chemotherapy combined with Lixuesheng plant extract complex plus Bolten whey lactoferrin capsule
Control group:Chemotherapy
Sponsors
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with advanced lung cancer confirmed by clinic, pathology and / or cytology; 2. Patients aged 18-75 years; 3. Patients without myelosuppression symptoms within 3 months before treatment; 4. Patients receiving standard conventional chemotherapy; 5. Patients whose expected survival time is more than 3 months; 6. Patients with nrs2002 total score >= 3; 7. Patients with KPS score of 60 or above; 8. The subjects of gastrointestinal function evaluation meeting the enteral nutrition indications.
Exclusion criteria
Exclusion criteria: 1. Patients with severe organic diseases of cardiovascular, brain, lung, kidney and other important organs; 2. Patients with mental illness or inability to cooperate; 3. Patients with severe immune system diseases; 4. Patients with severe infection or other complications; 5. Subjects who are participating in clinical trials of other drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of myelosuppression =grade III; | — |
Secondary
| Measure | Time frame |
|---|---|
| Onset time of myelosuppression = grade III;NRS2002 score after chemotherapy;KPS score after chemotherapy;QLQ-C30 score after chemotherapy;Rate of G-CSF salvage application;Rate of IL-11/TPO salvage application; | — |
Countries
China
Contacts
Public ContactXingsheng Hu
National Cancer Center / Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College
Outcome results
None listed